MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-26-0072255
Remedium Pharma Private Limited
Remedium Pharma Private Limited - healthcare in Pune, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹1.45 Cr
▲ 30% YoY
Net profit · FY 2025
₹3.37 Lakh
Net margin 2.3%
EBITDA · FY 2025
₹4.99 Lakh
EBITDA margin 3.4%
Authorised capital
₹2 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
10 yrs
Est. 2016
Directors on board
2
As per MCA filings
Active GSTINs
1
of 2 registered
About Remedium Pharma Private Limited
Data last updated:
Remedium Pharma Private Limited is a private limited company based in Pune, Maharashtra, India. It operates in the preventive healthcare segment of the healthcare sector. It was incorporated on 27 May 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U51909PN2016PTC164732. Its GSTIN is 27AAHCR7713H1Z6 (Maharashtra). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹2 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Yaseeran Aiyyaz Jahagirdar and Shakil Afzal Jagirdar.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Pune, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.45 Cr, a growth of 30% compared to the previous year. For the same year it recorded a net profit of ₹3.37 Lakh (net margin 2.3%) and EBITDA of ₹4.99 Lakh (EBITDA margin 3.4%). Revenue has grown at a compounded annual rate (CAGR) of 20% over three years and 21% over five years.
Remedium Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-26-0072255). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U51909PN2016PTC164732
Registration Number 164732
Incorporation Date 27 May 2016
ROC Pune
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-MH-26-0072255
Recognitions & Rankings of Remedium Pharma
Contact details
Remedium Pharma Private Limited's registered office is in Pune, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressShop – 42 Bld – E Gagan Avenue, Sn – 15/3/1A Kondhawa Budruk, Pune, Maharashtra, India – 411048
- IndustryHealthcare, Preventive Health Services
To see the full contact details of Remedium Pharma Private Limited, buy the company report.
Comprehensive company report
Remedium Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Remedium Pharma is human health and social work activities. In detail, this covers human health activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Human health and social work activities | 86 | Human health activities |
To see the full business activity and turnover split of Remedium Pharma Private Limited, buy the company report.
Financials of Remedium Pharma Private Limited
FY 2024 filings availableRemedium Pharma Private Limited reported revenue of ₹1.45 Cr (up 30% YoY) for FY 2025.
Revenue · FY 2025
₹1.45 Cr ▲ 30%
Net profit · FY 2025
₹3.37 Lakh margin 2.3%
EBITDA · FY 2025
₹4.99 Lakh margin 3.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 30%
3 years · compounded
▲ 20%
5 years · compounded
▲ 21%
EBITDA CAGR growth
1 year
▲ 20%
3 years · compounded
▲ 50%
5 years · compounded
▲ 22%
Revenue has grown at a compounded annual rate (CAGR) of 21% over five years, including 30% growth in the latest year. EBITDA rose 20% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4.99 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹3.37 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.4% | ||||
| Net Profit Margin | 2.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Remedium Pharma Private Limited, buy the company report.
Board of directors of Remedium Pharma Private Limited
Remedium Pharma has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Yaseeran Aiyyaz Jahagirdar | Director | 27 May 2016 | 10 Years 5 Months | Current |
| Shakil Afzal Jagirdar | Director | 27 May 2016 | 10 Years 5 Months | Current |
Peer comparison
Remedium Pharma Private Limited is compared with the 4 companies closest to it by revenue in the Healthcare industry (Preventive Healthcare Services), with the same principal business activity (human health activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Gethe's Hospital Private Limited | ₹1.46 Cr (FY 2025) | 5.0% | Pune, Maharashtra, India | |||
| Anvika Hospital Private Limited | ₹1.46 Cr (FY 2025) | 15.0% | Wardha, Maharashtra, India | |||
| Remedium Pharma Private Limitedthis company | ₹1.45 Cr (FY 2025) | ₹3.37 Lakh | 2.3% | 30.0% | Pune, Maharashtra, India | |
| Vashisht Clinic Private Limited | ₹1.45 Cr (FY 2024) | -43.0% | New Delhi, Delhi, India | |||
| Vrinda Labs and Research Centre Private Limited | ₹1.45 Cr (FY 2025) | 0.0% | New Delhi, Delhi, India |
To see the full peer comparison of Remedium Pharma Private Limited, buy the company report.
Auditor
Remedium Pharma Private Limited is audited by AST & Co. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| AST & Co. | FY 2023 | 136583W |
Shareholding
The shareholding of Remedium Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Remedium Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Remedium Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Remedium Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Remedium Pharma has 2 GST registrations: 1 active and 1 cancelled or inactive.
Total GSTINs
2
Active
1
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAHCR7713H1Z6 | Maharashtra | Active | 31 Jul 2017 |
To see the full GST registrations and return filing status of Remedium Pharma Private Limited, buy the company report.
Recent activity
Remedium Pharma Private Limited has 2 board changes on record since 2016: 2 appointments. The latest: Shakil Afzal Jagirdar was appointed as Director on 27 May 2016.
AGM
Remedium Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Remedium Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Pune.
Appointed
Shakil Afzal Jagirdar was appointed as Director.
Appointed
Yaseeran Aiyyaz Jahagirdar was appointed as Director.
Incorporation
27 May 2016
Remedium Pharma Private Limited was registered on 27 May 2016 with Roc Pune & aged 10 years 5 months as per MCA records.
Frequently asked questions
Remedium Pharma is an active private limited company based in Pune, Maharashtra, India. The company works in preventive health services, within the healthcare industry. It was incorporated on 27 May 2016 (10+ years old) and is registered under CIN U51909PN2016PTC164732.
Remedium Pharma has 2 current directors:
- Yaseeran Aiyyaz Jahagirdar - Director
- Shakil Afzal Jagirdar - Director
The latest financial statements of Remedium Pharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Remedium Pharma is 27AAHCR7713H1Z6, registered in Maharashtra. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Remedium Pharma is U51909PN2016PTC164732. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Remedium Pharma was incorporated on 27 May 2016, making it 10+ years old. It is registered with the Registrar of Companies, Pune.
The peers of Remedium Pharma by revenue are Gethe's Hospital Private Limited, Anvika Hospital Private Limited, Vashisht Clinic Private Limited, Vrinda Labs and Research Centre Private Limited, all in the Healthcare industry (Preventive Healthcare Services), with the same principal business activity (human health activities).
Shakil Afzal Jagirdar was appointed as Director on 27 May 2016. Yaseeran Aiyyaz Jahagirdar was appointed as Director on 27 May 2016.
Yes, Remedium Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-26-0072255).
The registered office of Remedium Pharma is at Shop – 42 Bld – E Gagan Avenue, Sn – 1531A Kondhawa Budruk, Pune, Maharashtra, India – 411048.
Remedium Pharma operates in the healthcare industry, in the preventive health services segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages